AMO Pharma Limited
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (NCT05004129) | AMO Pharma Limited | 2021-08-23 |
| Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy (NCT03692312) | AMO Pharma Limited | 2021-03-03 |
Track AMO Pharma Limited automatically
Every clearance here is in the API, with alerts when new ones post.